A detailed history of Bank Of America Corp transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 226,665 shares of ABEO stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
226,665
Previous 230,987 1.87%
Holding current value
$1.32 Million
Previous $979,000 46.27%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.12 - $6.32 $17,806 - $27,315
-4,322 Reduced 1.87%
226,665 $1.43 Million
Q2 2024

Aug 14, 2024

BUY
$3.17 - $8.05 $659,290 - $1.67 Million
207,978 Added 903.9%
230,987 $979,000
Q1 2024

May 15, 2024

SELL
$4.07 - $8.68 $114,220 - $243,595
-28,064 Reduced 54.95%
23,009 $166,000
Q4 2023

Feb 14, 2024

BUY
$3.71 - $5.14 $189,480 - $262,515
51,073 New
51,073 $255,000
Q4 2022

Feb 10, 2023

BUY
$2.4 - $5.65 $76 - $180
32 New
32 $0

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $34.8M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.